The Centers for Disease Control and Prevention recommends how to use vaccines and its vaccine advisers are set to discuss the shots for the youngest kids Friday and vote on Saturday
The U.S. Food and Drug Administration (FDA) has announced tentative June dates for the meeting of its advisory committee to discuss authorizing COVID-19 vaccines among young children below the age of five years.
Moderna says Phase 2/3 trials of its COVID-19 vaccines for children one for those aged six months to 2 years and another for those aged between 2 and 6 showed a "robust neutralizing antibody response" along with "a favorable safety profile."
Moderna says Phase 2/3 trials of its COVID-19 vaccines for children one for those aged six months to 2 years and another for those aged between 2 and 6 showed a "robust neutralizing antibody response" along with "a favorable safety profile."